Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2

被引:10
|
作者
Yang, Fan [1 ]
Zhao, Hai [2 ]
Liu, Hongtao [1 ]
Wu, Xiuying [1 ]
Li, Yongnan [1 ]
机构
[1] China Med Univ, Dept Anesthesiol, Shengjing Hosp, Sanhao St 36, Shenyang 110004, Peoples R China
[2] Shenyang Med Coll, Clin Skills Ctr, Huanghe St 146, Shenyang 110034, Peoples R China
关键词
SARS-CoV-2; Central nervous system; Olfactory disorders; ACE2; CYTOKINE STORM; COVID-19; CONSEQUENCES; DISEASE; ANOSMIA; NLRP3;
D O I
10.1016/j.brainresbull.2021.09.015
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its threat to humans have drawn worldwide attention. The acute and long-term effects of SARS-CoV-2 on the nervous system pose major public health challenges. Patients with SARS-CoV-2 present diverse symptoms of the central nervous system. Exploring the mechanism of coronavirus damage to the nervous system is essential for reducing the long-term neurological complications of COVID-19. Despite rapid progress in characterizing SARS-CoV-2, the long-term effects of COVID-19 on the brain remain unclear. The possible mechanisms of SARS-CoV-2 injury to the central nervous system include: 1) direct injury of nerve cells, 2) activation of the immune system and in-flammatory cytokines caused by systemic infection, 3) a high affinity of the SARS-CoV-2 spike glycoprotein for the angiotensin-converting enzyme ACE2, 4) cerebrovascular disease caused by hypoxia and coagulation dysfunction, and 5) a systemic inflammatory response that promotes cognitive impairment and neurodegener-ative diseases. Although we do not fully understand the mechanism by which SARS-CoV-2 causes nerve injury, we hope to provide a framework by reviewing the clinical manifestations, complications, and possible mecha-nisms of neurological damage caused by SARS-CoV-2. With hope, this will facilitate the early identification, diagnosis, and treatment of possible neurological sequelae, which could contribute toward improving patient prognosis and preventing transmission.
引用
收藏
页码:155 / 163
页数:9
相关论文
共 50 条
  • [31] Central Nervous System Inflammatory Diseases after mRNA SARS-CoV-2 Vaccination
    Quek, Amy May Lin
    Koh, Jasmine Shimin
    Goh, Yihui
    Hoe, Rebecca Hui Min
    Yong, Ming Hui
    Hui, Andrew Che-Fai Andrew
    Yong, Kok Pin
    Tu, Tian Ming
    Tow, Sharon Lee Choon
    Milea, Dan
    Thomas, Terrence
    Thirugnanam, Umapathi N.
    Seet, Raymond Chee Seong
    Tan, Kevin
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (07) : NP2 - NP3
  • [32] SARS-CoV-2: Nutritional determinants of reducing the risk of infection of the central nervous system
    Szponar, Lucjan
    Matczuk, Ewa
    POSTEPY PSYCHIATRII I NEUROLOGII, 2021, 30 (02): : 130 - 140
  • [33] How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis
    Panariello, Fabio
    Cellini, Lorenzo
    Speciani, Maurizio
    De Ronchi, Diana
    Atti, Anna Rita
    FRONTIERS IN PSYCHIATRY, 2020, 11
  • [34] Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection
    Chaumont, H.
    San-Galli, A.
    Martino, F.
    Couratier, C.
    Joguet, G.
    Carles, M.
    Roze, E.
    Lannuzel, A.
    JOURNAL OF NEUROLOGY, 2020, 267 (11) : 3121 - 3127
  • [35] Evolution of SARS-CoV-2 in the murine central nervous system drives viral diversification
    Class, Jacob
    Simons, Lacy M.
    Lorenzo-Redondo, Ramon
    Achi, Jazmin Galvan
    Cooper, Laura
    Dangi, Tanushree
    Penaloza-MacMaster, Pablo
    Ozer, Egon A.
    Lutz, Sarah E.
    Rong, Lijun
    Hultquist, Judd F.
    Richner, Justin M.
    NATURE MICROBIOLOGY, 2024, 9 (09): : 2383 - 2394
  • [36] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System
    De Felice, Fernanda G.
    Tovar-Moll, Fernanda
    Moll, Jorge
    Munoz, Douglas P.
    Ferreira, Sergio T.
    TRENDS IN NEUROSCIENCES, 2020, 43 (06) : 355 - 357
  • [37] Are there cutaneous manifestations of SARS-CoV-2?
    Drerup K.A.
    Gläser R.
    Der Hautarzt, 2020, 71 (9): : 734 - 736
  • [38] Extrapulmonary SARS-CoV-2 manifestations
    Thiago Carvalho
    Nature Medicine, 2020, 26 : 1806 - 1806
  • [39] SARS-CoV-2 and Age - Transmission, Disease Manifestations and Mechanisms.
    Cutrera, Renato
    Ghirardo, S.
    PEDIATRIC PULMONOLOGY, 2021, 56 : S26 - S27
  • [40] The effect of SARS-CoV-2 on the nervous system: a review of neurological impacts caused by human coronaviruses
    Day, Colin
    Studders, Carson
    Arklie, Kim
    Kaur, Asees
    Teetzen, Kyra
    Kirsch, Rebecca
    Abelseth, Laila
    Fraser, Ian
    Abelseth, Emily
    Willerth, Stephanie M.
    REVIEWS IN THE NEUROSCIENCES, 2022, 33 (03) : 257 - 268